ONE STOP SOLUTION FOR DRUG DELIVERY Nanox focuses on the development of pharmaceutical products with complex drug delivery technologies like liposomes, pegylated liposomes, and microspheres depot with PLGA (polylactide - polyglycolide copolymers) formulations. Nanox owns worldwide rights for GM1-Nanomicelles, an innovative carrier for oncological drugs in preclinical stage currently being tested in neuro-oncology indications due its unique capacity to pass the Blood-Brain barrier
